ZYME

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Total revenue 27.11 M48.73 M27.61 M2.52 M2.41 M4.59 M 37.13 M Gross profit 27.11 M48.73 M27.61 M2.52 M2.41 M4.59 M 37.13 M Operating expenses 52.72 M49.4 M49.72 M46.67 M49.53 M19.69 M 165.6 M Selling/general/admin expenses 16.98 M14.95 M14.15 M15.43 M15.07 M19.34 M 63.98 M Research & development 35.74 M34.45 M35.58 M31.23 M34.46 M27.43 M 128.71 M Operating income -25.61 M-674 K-22.11 M-44.15 M-47.12 M-42.18 M -155.56 M Non-Operating Income, Total 49 K-621 K315 K-302 K120 K196 K 329 K Interest expense, net of interest capitalized ————26 K87 K — Non-Operating Income, excl. Interest Expenses -2 000-613 K289 K-284 K94 K109 K 208 K Unusual income/expense 51 K-8 00026 K-18 K—— — Pretax income -22.14 M2.13 M-18.27 M-41.48 M-46.35 M-45.29 M -151.39 M Equity in earnings —————— — Taxes 496 K-186 K1.34 M-270 K-2.19 M-273 K -1.4 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -22.64 M2.32 M-19.6 M-41.21 M-44.16 M-45.02 M -149.99 M Discontinued operations —————— — Net income -22.64 M2.32 M-19.6 M-41.21 M-44.16 M-45.02 M -149.99 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -22.81 M2.32 M-19.77 M-41.06 M-44.22 M-45.02 M -150.07 M Basic earnings per share (Basic EPS) -0.30.03-0.26-0.55-0.59-0.62 -2.02 Diluted earnings per share (Diluted EPS) -0.30.03-0.26-0.55-0.59-0.62 -2.02 Average basic shares outstanding 75.17 M75.34 M75.77 M75.4 M74.67 M72.99 M — Diluted shares outstanding 75.23 M77.38 M75.78 M75.41 M74.69 M72.99 M — EBITDA -23.02 M3.43 M-17.33 M-39.2 M-45.19 M-40.78 M -142.5 M EBIT -25.61 M-674 K-22.11 M-44.15 M-47.12 M-42.18 M -155.56 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 2.6 M4.11 M4.78 M4.95 M1.93 M1.4 M 13.06 M